A study published earlier this year in the Journal of Neuro-Oncology indicates that sonodynamic therapy (SDT) safely destroys GBM cells while preserving healthy brain tissue. Using a noninvasive ...

Researchers have created a highly detailed spatial multiomic atlas to date of glioma tumour microenvironments.

What Is Modeyso Used For? Modeyso is used to treat a type of recurrent brain cancer known as a diffuse midline glioma with a specific genetic mutation known as histone 3 (H3) K27M. Diffuse midline ...

A rare and aggressive type of brain cancer that often becomes fatal a year after its diagnosis in children and young adults now has its first FDA-approved therapy, a once-weekly capsule from Jazz ...

Varun Venkataramani is the winner of the 2025 Eppendorf Award for Young European Investigators. A neurologist and group leader at Heidelberg University Hospital, Germany, his work in cancer ...

In a surprising and hopeful turn of events, a 40-year-old father is living his best life in his second innings, after he was diagnosed with terminal glioblastoma in 2023. In fact, three years later, ...

PHILADELPHIA--(BUSINESS WIRE)--Geneos Therapeutics, a clinical-stage biotherapeutics company developing personalized immunotherapies for cancer (PICs), today announced that two patients with ...

The Ohio State University’s James Cancer Hospital has treated the world’s first brain cancer patient to receive a new radiation technology that attacks tumors from within, the university recently ...

COPENHAGEN, Denmark, Dec. 18, 2025 /PRNewswire/ -- Curasight A/S ("Curasight" or "the Company" – TICKER: CURAS) today announced the successful and safe dosing of the first patient in the Phase 1 trial ...

A 57-year-old UK father of four recently made headlines when he revealed the bizarre clue that preceded his Stage 4 glioblastoma diagnosis — a “strange sweet caramel smell.” “We didn’t think much of ...